Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2009 Jan 20;236(1):109–114. doi: 10.1016/j.taap.2008.12.024

Fig 4.

Fig 4

Upper. Hepatic mRNA expression of Nqo1, Gclc, and Ho-1 in wild-type mice after various doses of CDDO-Im. Livers were removed 6 h after dosing and mRNA quantified by the bDNA assay. Lower. Hepatic mRNA expression of Nqo1, Gclc, and Ho-1 in wild-type mice at different time points after CDDO-Im (1 mg/kg, i.p.) administration. mRNA was quantified by the bDNA assay. Data are expressed as relative to control mean ± S.E.M. Asterisks (*) indicate statistically significant differences between CDDO-Im treated and control groups (p ≤ 0.05).